#WHO welcomes preliminary results about #dexamethasone use in treating critically ill #COVID_19 patients
![]() 3506 Wednesday, 17 June, 2020, 11:35 The World Health Organization (WHO) welcomes the initial clinical trial results from the United Kingdom (UK) that show dexamethasone, a corticosteroid, can be lifesaving for patients who are critically ill with COVID-19. For patients on ventilators, the treatment was shown to reduce mortality by about one third, and for patients requiring only oxygen, mortality was cut by about one fifth, according to preliminary findings shared with WHO. The benefit was only seen in patients seriously ill with COVID-19, and was not observed in patients with milder disease. |
Apple debuts iPhone 17
372Yesterday, 23:08Yuri Ivashechkin, the creator of the Su-25 attack aircraft, has died
109603.09.2025, 13:33Türkiye to build spaceport in Somalia for rocket, missile tests
290405.08.2025, 18:17A woman in India has been diagnosed with a unique blood type
380130.07.2025, 14:21Global media forum with Aliyev's participation to be held in occupied Stepanakert
468019.07.2025, 17:30SpaceX Starship rocket explodes during test flight (video)
688819.06.2025, 12:34Elon Musk announces XChat feature
772202.06.2025, 13:04The world's lowest car has been created in Taiwan (video)
918826.05.2025, 11:40